We operate from a purpose-built 65,000ft² (6,000m²) GMP facility in Bristol, designed to support cell and gene therapy developers from early-stage clinical programmes through to commercial manufacture. Our facility includes fully qualified Grade C cleanrooms, integrated fill-finish capability, QC labs, GMP warehousing, and 12,000ft² of expansion space for additional clinical, pivotal, or commercial manufacturing capacity.
Apr 11, 2025
What is our scale of operation?
We operate from a purpose-built 65,000ft² (6,000m²) GMP facility in Bristol, designed to support cell and gene therapy developers from early-stage clinical programmes through to commercial manufacture. Our facility includes fully qualified Grade C cleanrooms, integrated fill-finish capability, QC labs, GMP warehousing, and 12,000ft² of expansion space for additional clinical, pivotal, or commercial manufacturing capacity.
Latest News
eXmoor Pharma and UCL forge a strategic collaboration to speed the advancement of cell and gene therapies
Dec 2, 2025
Industry News
eXmoor Pharma and Royal Free London launch strategic collaboration to strengthen UK cell and gene therapy manufacturing pathway
Nov 26, 2025
Industry News
eXmoor Pharma and Siam Bioscience form strategic partnership to establish leading CGT services in Southeast Asia
Sep 23, 2025
Industry News
Let’s Accelerate Your Therapy Together
Whether you're in early-stage development or scaling up for commercial production, eXmoor Pharma provides the expertise and flexibility you need. Partner with us to move your therapy forward with confidence.